[Skip to content]

Royal Brompton & Harefield NHS Foundation Trust
Our research
Search our Site
Bronchiectasis treatments

Our research

Active research studies

The Trust hosts a variety of research studies covering the breadth of its clinical practice. These are funded by a variety of sponsors including National Institute for Health Research (NIHR), UK research councils, European funding agencies, research charities and industry. 

Below is a list of approved projects that are currently recruiting volunteers.


Research studies

Specialty CategoryResearch titleStudy contact informationMore info
Heart failureA Phase II/ III Randomized, Double Blind Placebo, Controlled Study to Evaluate the Effect of GS6615 on Exercise Capacity in Subjects with Symptomatic HCMSally Anne McNeil 
Heart failureMicraTM Transcatheter Pacing System Post-Approval RegistryShu Fang Wang (RB) / Paula Rogers (HH)More info
Heart failurePARAGON: A multicenter, randomized, double-blind, parallel group, active-controlled study to evaluate the efficacy and safety of LCZ696 compared to valsartan, on morbidity and mortality in heart failure patients (NYHA Class II-IV) with preserved ejectionZoreh FarzadMore info
Heart failureROX CONTROL HTN Registry: To Evaluate the ROX Coupler in Patients with Resistant or Uncontrolled HypertensionDebra DempsterMore info
Heart failureA multicenter, randomized, double-blind, crossover placebo-controlled Phase II study to assess the effect of serelaxin versus placebo on high sensitivity cardiac troponin I (hs-cTnI) release in patients with chronic heart failure after exercise when usedSophie WelchMore info
Heart failureGALACTIC-HF - A double-blind, randomised and placebo controlled study to assess the efficacy and safety of Omecamtiv Mecarbil on mortality and morbidity in subjects with chronic heart failure with reduced ejection fraction. Rebecca Lucas 
Heart failureVICTORIA-HF - Phase 3 double blind, randomised, placebo controlled trial of the efficacy and safety of the oral sGC stimulator Vericiguat in subjects with heart failure with reduced ejection fraction. Rebecca Lucas 
Interstitial lung disease & pulmonary fibrosisIPF-PRoMAnne-Marie RussellMore info
Interstitial lung disease & pulmonary fibrosisILD Controls V1.0Johanna Lewis or Lyn BinghamMore info
Interstitial lung disease & pulmonary fibrosisTreating pulmonary fibrosis with co-trimoxazoleZainab Sanni-AlasheMore info

See details of the Trust’s performance for all clinical trials reported to the NIHR (PDF, 276KB), for the set-up and delivery of studies in the period 1 October 2016 to 30 September 2017.

Royal Brompton

Sydney Street,
London SW3 6NP
Tel: +44 (0)20 7352 8121